» Articles » PMID: 38861202

SPHK1 Promotes Pancreatic Cancer Lymphangiogenesis Through the Activation of ERK in LECs

Overview
Journal Mol Biotechnol
Publisher Springer
Date 2024 Jun 11
PMID 38861202
Authors
Affiliations
Soon will be listed here.
Abstract

Lymphatic metastasis is related to an unsatisfactory prognosis in pancreatic cancer. Sphingosine kinase 1 (SPHK1) is an oncogene in cancer. However, the potential effect of SPHK1 on the lymphangiogenesis of pancreatic cancer is little known. In this study, the expression level and role of SPHK1 in pancreatic cancer were evaluated to explore the underlying mechanism involved. The expression of SPHK1 and the lymphatic vessel density (LVD) in pancreatic cancer patient tissue were investigated by immunohistochemistry. The role of SPHK1 in lymphangiogenesis was verified in vitro. Elevated expression of SPHK1 was strongly related to high LVD in pancreatic cancer patient tissue. Silencing of SPHK1 in pancreatic cancer cells observably inhibited lymphangiogenesis. Furthermore, the downregulation of SPHK1 markedly attenuated the phosphorylation of extracellular signal-regulated kinase in lymphatic endothelial cells. This study revealed that SPHK1 might play a crucial role in pancreatic cancer lymphangiogenesis.

Citing Articles

Exosomal SphK1 from colorectal cancer cells promotes cancer cell migration and activates hepatic stellate cells.

Zhang W, Xu C Mol Med Rep. 2025; 31(3).

PMID: 39930826 PMC: 11795250. DOI: 10.3892/mmr.2025.13438.


Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential.

Limbu K, Chhetri R, Kim S, Shrestha J, Oh Y, Baek D Cancer Cell Int. 2024; 24(1):353.

PMID: 39462385 PMC: 11514880. DOI: 10.1186/s12935-024-03535-7.

References
1.
Zorgetto V, Silveira G, Oliveira-Costa J, Soave D, Soares F, Ribeiro-Silva A . The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas. Diagn Pathol. 2013; 8:170. PMC: 3816792. DOI: 10.1186/1746-1596-8-170. View

2.
Li A, Zhu L, Lei N, Wan J, Duan X, Liu S . S100A4-dependent glycolysis promotes lymphatic vessel sprouting in tumor. Angiogenesis. 2022; 26(1):19-36. DOI: 10.1007/s10456-022-09845-6. View

3.
Luo Y, Li Z, Kong Y, He W, Zheng H, An M . KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer. J Clin Invest. 2022; 132(14). PMC: 9282935. DOI: 10.1172/JCI157644. View

4.
Ren B, Cui M, Yang G, Wang H, Feng M, You L . Tumor microenvironment participates in metastasis of pancreatic cancer. Mol Cancer. 2018; 17(1):108. PMC: 6065152. DOI: 10.1186/s12943-018-0858-1. View

5.
Hinshaw D, Shevde L . The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019; 79(18):4557-4566. PMC: 6744958. DOI: 10.1158/0008-5472.CAN-18-3962. View